Sam Brusco, Associate Editor03.29.22
Life Spine has achieved U.S. Food and Drug Administration (FDA) clearance for its SImpact SI joint fixation system for posterior-oblique approaches.
SImpact allows the same instrumentation and screws to be used in both direct lateral or newly-cleared posterior-oblique approaches. This means physicians can choose the appropriate approach to suit the patient’s anatomy and pathology.
“SImpact offers a complete solution for SI joint fixation. This additional clearance furthers our SI portfolio by expanding the capabilities of the system to be utilized in a Posterior-Oblique approach,” Mariusz Knap, Life Spine’s senior VP of marketing told the press. “The system offers a variety of configurations including 8mm Lag screw, 12mm SImpact screw and a 14.5mm Revision screw making it one of the most robust SI systems on the market.”
SImpact also features a self-drilling and self-harvesting screw design as well as an anti-rotational sleeve to prevent screw back-out.
SImpact allows the same instrumentation and screws to be used in both direct lateral or newly-cleared posterior-oblique approaches. This means physicians can choose the appropriate approach to suit the patient’s anatomy and pathology.
“SImpact offers a complete solution for SI joint fixation. This additional clearance furthers our SI portfolio by expanding the capabilities of the system to be utilized in a Posterior-Oblique approach,” Mariusz Knap, Life Spine’s senior VP of marketing told the press. “The system offers a variety of configurations including 8mm Lag screw, 12mm SImpact screw and a 14.5mm Revision screw making it one of the most robust SI systems on the market.”
SImpact also features a self-drilling and self-harvesting screw design as well as an anti-rotational sleeve to prevent screw back-out.